世界の等温核酸増幅技術(INAAT)市場規模・現状・予測2021-2027

【英語タイトル】Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR3289)・商品コード:QY21APR3289
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:159
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、等温核酸増幅技術(INAAT)の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(ループ媒介等温増幅、核酸配列増幅、ローリングサークル増幅、シングルプライマー等温増幅、ヘリカーゼ依存性等温DNA増幅、リコンビナーゼポリメラーゼ増幅、鎖置換増幅)、用途別市場規模(感染症診断、がん検診、がん診断、がん研究・実験室研究、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・等温核酸増幅技術(INAAT)の市場動向
・企業の競争状況、市場シェア
・等温核酸増幅技術(INAAT)の種類別市場規模(ループ媒介等温増幅、核酸配列増幅、ローリングサークル増幅、シングルプライマー等温増幅、ヘリカーゼ依存性等温DNA増幅、リコンビナーゼポリメラーゼ増幅、鎖置換増幅)
・等温核酸増幅技術(INAAT)の用途別市場規模(感染症診断、がん検診、がん診断、がん研究・実験室研究、その他)
・等温核酸増幅技術(INAAT)の北米市場規模2016-2027(アメリカ、カナダ)
・等温核酸増幅技術(INAAT)の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・等温核酸増幅技術(INAAT)のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・等温核酸増幅技術(INAAT)の中南米市場規模2016-2027(メキシコ、ブラジル)
・等温核酸増幅技術(INAAT)の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Grifols、Hologic、Abbott Laboratories、BD、Meridian Bioscience、Eiken Chemical、Quidel Corporation、QIAGEN、bioMerieux、Tecan、DiaSorin、Thermo Fisher Scientific、Illumina、New England Biolabs、TwistDx、Mast Group、Lucigen Corporation、Ustar Biotechnologies、Genomtec、Jena Bioscience、OptiGene、Sysmex Corporation、Premier Biosoft、mFluiDx、Cangene)
・結論
【レポートの概要】

Market Analysis and Insights: Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market
The global Isothermal Nucleic Acid Amplification Technology (INAAT) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Isothermal Nucleic Acid Amplification Technology (INAAT) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Isothermal Nucleic Acid Amplification Technology (INAAT) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Isothermal Nucleic Acid Amplification Technology (INAAT) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Isothermal Nucleic Acid Amplification Technology (INAAT) market.

Global Isothermal Nucleic Acid Amplification Technology (INAAT) Scope and Market Size
Isothermal Nucleic Acid Amplification Technology (INAAT) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Isothermal Nucleic Acid Amplification Technology (INAAT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
by Technology
Loop-mediated Isothermal Amplification
Nucleic Acid Sequence-based Amplification
Rolling Circle Amplification
Single Primer Isothermal Amplification
Helicase-dependent Isothermal DNA Amplification
Recombinase Polymerase Amplification
Strand Displacement Amplification
by Product Type
Assay
Kits
Reagents

Segment by Application
Infectious Disease Diagnosis
Blood Screening
Cancer Diagnosis
Cancer Research and Laboratory Research
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Grifols
Hologic
Abbott Laboratories
BD
Meridian Bioscience
Eiken Chemical
Quidel Corporation
QIAGEN
bioMerieux
Tecan
DiaSorin
Thermo Fisher Scientific
Illumina
New England Biolabs
TwistDx
Mast Group
Lucigen Corporation
Ustar Biotechnologies
Genomtec
Jena Bioscience
OptiGene
Sysmex Corporation
Premier Biosoft

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Loop-mediated Isothermal Amplification
1.2.3 Nucleic Acid Sequence-based Amplification
1.2.4 Rolling Circle Amplification
1.2.5 Single Primer Isothermal Amplification
1.2.6 Helicase-dependent Isothermal DNA Amplification
1.2.7 Recombinase Polymerase Amplification
1.2.8 Strand Displacement Amplification
1.3 Market by Application
1.3.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Infectious Disease Diagnosis
1.3.3 Blood Screening
1.3.4 Cancer Diagnosis
1.3.5 Cancer Research and Laboratory Research
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Perspective (2016-2027)
2.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Growth Trends by Regions
2.2.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Share by Regions (2016-2021)
2.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Regions (2022-2027)
2.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Dynamic
2.3.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Trends
2.3.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers
2.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Challenges
2.3.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Revenue
3.1.1 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Revenue (2016-2021)
3.1.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Players (2016-2021)
3.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue
3.4 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Concentration Ratio
3.4.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue in 2020
3.5 Isothermal Nucleic Acid Amplification Technology (INAAT) Key Players Head office and Area Served
3.6 Key Players Isothermal Nucleic Acid Amplification Technology (INAAT) Product Solution and Service
3.7 Date of Enter into Isothermal Nucleic Acid Amplification Technology (INAAT) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Isothermal Nucleic Acid Amplification Technology (INAAT) Breakdown Data by Type
4.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Type (2016-2021)
4.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Type (2022-2027)

5 Isothermal Nucleic Acid Amplification Technology (INAAT) Breakdown Data by Application
5.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Application (2016-2021)
5.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2016-2027)
6.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type
6.2.1 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2021)
6.2.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2022-2027)
6.2.3 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2027)
6.3 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application
6.3.1 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2021)
6.3.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2022-2027)
6.3.3 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2027)
6.4 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country
6.4.1 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2016-2021)
6.4.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2016-2027)
7.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type
7.2.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2021)
7.2.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2022-2027)
7.2.3 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2027)
7.3 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application
7.3.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2021)
7.3.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2022-2027)
7.3.3 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2027)
7.4 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country
7.4.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2016-2021)
7.4.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2016-2027)
8.2 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type
8.2.1 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2027)
8.3 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application
8.3.1 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2027)
8.4 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region
8.4.1 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2016-2027)
9.2 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type
9.2.1 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2021)
9.2.2 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2022-2027)
9.2.3 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2027)
9.3 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application
9.3.1 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2021)
9.3.2 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2022-2027)
9.3.3 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2027)
9.4 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country
9.4.1 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2016-2021)
9.4.2 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2016-2027)
10.2 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type
10.2.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2027)
10.3 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application
10.3.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2027)
10.4 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country
10.4.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Grifols
11.1.1 Grifols Company Details
11.1.2 Grifols Business Overview
11.1.3 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.1.4 Grifols Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.1.5 Grifols Recent Development
11.2 Hologic
11.2.1 Hologic Company Details
11.2.2 Hologic Business Overview
11.2.3 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.2.4 Hologic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.2.5 Hologic Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.3.4 Abbott Laboratories Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.4.4 BD Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.4.5 BD Recent Development
11.5 Meridian Bioscience
11.5.1 Meridian Bioscience Company Details
11.5.2 Meridian Bioscience Business Overview
11.5.3 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.5.4 Meridian Bioscience Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.5.5 Meridian Bioscience Recent Development
11.6 Eiken Chemical
11.6.1 Eiken Chemical Company Details
11.6.2 Eiken Chemical Business Overview
11.6.3 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.6.4 Eiken Chemical Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.6.5 Eiken Chemical Recent Development
11.7 Quidel Corporation
11.7.1 Quidel Corporation Company Details
11.7.2 Quidel Corporation Business Overview
11.7.3 Quidel Corporation Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.7.4 Quidel Corporation Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.7.5 Quidel Corporation Recent Development
11.8 QIAGEN
11.8.1 QIAGEN Company Details
11.8.2 QIAGEN Business Overview
11.8.3 QIAGEN Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.8.4 QIAGEN Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.8.5 QIAGEN Recent Development
11.9 bioMerieux
11.9.1 bioMerieux Company Details
11.9.2 bioMerieux Business Overview
11.9.3 bioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.9.4 bioMerieux Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.9.5 bioMerieux Recent Development
11.10 Tecan
11.10.1 Tecan Company Details
11.10.2 Tecan Business Overview
11.10.3 Tecan Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.10.4 Tecan Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.10.5 Tecan Recent Development
11.11 DiaSorin
11.11.1 DiaSorin Company Details
11.11.2 DiaSorin Business Overview
11.11.3 DiaSorin Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.11.4 DiaSorin Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.11.5 DiaSorin Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Details
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.12.4 Thermo Fisher Scientific Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Illumina
11.13.1 Illumina Company Details
11.13.2 Illumina Business Overview
11.13.3 Illumina Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.13.4 Illumina Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.13.5 Illumina Recent Development
11.14 New England Biolabs
11.14.1 New England Biolabs Company Details
11.14.2 New England Biolabs Business Overview
11.14.3 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.14.4 New England Biolabs Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.14.5 New England Biolabs Recent Development
11.15 TwistDx
11.15.1 TwistDx Company Details
11.15.2 TwistDx Business Overview
11.15.3 TwistDx Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.15.4 TwistDx Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.15.5 TwistDx Recent Development
11.16 Mast Group
11.16.1 Mast Group Company Details
11.16.2 Mast Group Business Overview
11.16.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.16.4 Mast Group Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.16.5 Mast Group Recent Development
11.17 Lucigen Corporation
11.17.1 Lucigen Corporation Company Details
11.17.2 Lucigen Corporation Business Overview
11.17.3 Lucigen Corporation Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.17.4 Lucigen Corporation Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.17.5 Lucigen Corporation Recent Development
11.18 Ustar Biotechnologies
11.18.1 Ustar Biotechnologies Company Details
11.18.2 Ustar Biotechnologies Business Overview
11.18.3 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.18.4 Ustar Biotechnologies Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.18.5 Ustar Biotechnologies Recent Development
11.18 Genomtec
11.25.1 Genomtec Company Details
11.25.2 Genomtec Business Overview
11.25.3 Genomtec Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.25.4 Genomtec Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.25.5 Genomtec Recent Development
11.20 Jena Bioscience
11.20.1 Jena Bioscience Company Details
11.20.2 Jena Bioscience Business Overview
11.20.3 Jena Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.20.4 Jena Bioscience Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.20.5 Jena Bioscience Recent Development
11.21 OptiGene
11.21.1 OptiGene Company Details
11.21.2 OptiGene Business Overview
11.21.3 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.21.4 OptiGene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.21.5 OptiGene Recent Development
11.22 Sysmex Corporation
11.22.1 Sysmex Corporation Company Details
11.22.2 Sysmex Corporation Business Overview
11.22.3 Sysmex Corporation Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.22.4 Sysmex Corporation Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.22.5 Sysmex Corporation Recent Development
11.23 Premier Biosoft
11.23.1 Premier Biosoft Company Details
11.23.2 Premier Biosoft Business Overview
11.23.3 Premier Biosoft Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.23.4 Premier Biosoft Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.23.5 Premier Biosoft Recent Development
11.24 mFluiDx
11.24.1 mFluiDx Company Details
11.24.2 mFluiDx Business Overview
11.24.3 mFluiDx Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.24.4 mFluiDx Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.24.5 mFluiDx Recent Development
11.25 Cangene
11.25.1 Cangene Company Details
11.25.2 Cangene Business Overview
11.25.3 Cangene Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.25.4 Cangene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
11.25.5 Cangene Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Loop-mediated Isothermal Amplification
Table 3. Key Players of Nucleic Acid Sequence-based Amplification
Table 4. Key Players of Rolling Circle Amplification
Table 5. Key Players of Single Primer Isothermal Amplification
Table 6. Key Players of Helicase-dependent Isothermal DNA Amplification
Table 7. Key Players of Recombinase Polymerase Amplification
Table 8. Key Players of Strand Displacement Amplification
Table 9. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Regions (2016-2021)
Table 13. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Regions (2022-2027)
Table 15. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Trends
Table 16. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers
Table 17. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Challenges
Table 18. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Restraints
Table 19. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Players (2016-2021)
Table 21. Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) as of 2020)
Table 22. Ranking of Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Isothermal Nucleic Acid Amplification Technology (INAAT) Product Solution and Service
Table 26. Date of Enter into Isothermal Nucleic Acid Amplification Technology (INAAT) Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Type (2016-2021)
Table 30. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Application (2016-2021)
Table 34. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2022-2027) & (US$ Million)
Table 66. Grifols Company Details
Table 67. Grifols Business Overview
Table 68. Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 69. Grifols Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 70. Grifols Recent Development
Table 71. Hologic Company Details
Table 72. Hologic Business Overview
Table 73. Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 74. Hologic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 75. Hologic Recent Development
Table 76. Abbott Laboratories Company Details
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 79. Abbott Laboratories Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 80. Abbott Laboratories Recent Development
Table 81. BD Company Details
Table 82. BD Business Overview
Table 83. BD Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 84. BD Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 85. BD Recent Development
Table 86. Meridian Bioscience Company Details
Table 87. Meridian Bioscience Business Overview
Table 88. Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 89. Meridian Bioscience Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 90. Meridian Bioscience Recent Development
Table 91. Eiken Chemical Company Details
Table 92. Eiken Chemical Business Overview
Table 93. Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 94. Eiken Chemical Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 95. Eiken Chemical Recent Development
Table 96. Quidel Corporation Company Details
Table 97. Quidel Corporation Business Overview
Table 98. Quidel Corporation Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 99. Quidel Corporation Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 100. Quidel Corporation Recent Development
Table 101. QIAGEN Company Details
Table 102. QIAGEN Business Overview
Table 103. QIAGEN Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 104. QIAGEN Recent Development
Table 105. bioMerieux Company Details
Table 106. bioMerieux Business Overview
Table 107. bioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 108. bioMerieux Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 109. bioMerieux Recent Development
Table 110. Tecan Company Details
Table 111. Tecan Business Overview
Table 112. Tecan Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 113. Tecan Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 114. Tecan Recent Development
Table 115. DiaSorin Company Details
Table 116. DiaSorin Business Overview
Table 117. DiaSorin Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 118. DiaSorin Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 119. DiaSorin Recent Development
Table 120. Thermo Fisher Scientific Company Details
Table 121. Thermo Fisher Scientific Business Overview
Table 122. Thermo Fisher Scientific Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 123. Thermo Fisher Scientific Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 124. Thermo Fisher Scientific Recent Development
Table 125. Illumina Company Details
Table 126. Illumina Business Overview
Table 127. Illumina Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 128. Illumina Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 129. Illumina Recent Development
Table 130. New England Biolabs Company Details
Table 131. New England Biolabs Business Overview
Table 132. New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 133. New England Biolabs Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 134. New England Biolabs Recent Development
Table 135. TwistDx Company Details
Table 136. TwistDx Business Overview
Table 137. TwistDx Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 138. TwistDx Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 139. TwistDx Recent Development
Table 140. Mast Group Company Details
Table 141. Mast Group Business Overview
Table 142. Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 143. Mast Group Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 144. Mast Group Recent Development
Table 145. Lucigen Corporation Company Details
Table 146. Lucigen Corporation Business Overview
Table 147. Lucigen Corporation Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 148. Lucigen Corporation Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 149. Lucigen Corporation Recent Development
Table 150. Ustar Biotechnologies Company Details
Table 151. Ustar Biotechnologies Business Overview
Table 152. Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 153. Ustar Biotechnologies Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 154. Ustar Biotechnologies Recent Development
Table 155. Genomtec Company Details
Table 156. Genomtec Business Overview
Table 157. Genomtec Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 158. Genomtec Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 159. Genomtec Recent Development
Table 160. Jena Bioscience Company Details
Table 161. Jena Bioscience Business Overview
Table 162. Jena Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 163. Jena Bioscience Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 164. Jena Bioscience Recent Development
Table 165. OptiGene Company Details
Table 166. OptiGene Business Overview
Table 167. OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 168. OptiGene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 169. OptiGene Recent Development
Table 170. Sysmex Corporation Company Details
Table 171. Sysmex Corporation Business Overview
Table 172. Sysmex Corporation Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 173. Sysmex Corporation Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 174. Sysmex Corporation Recent Development
Table 175. Premier Biosoft Company Details
Table 176. Premier Biosoft Business Overview
Table 177. Premier Biosoft Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 178. Premier Biosoft Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 179. Premier Biosoft Recent Development
Table 180. mFluiDx Company Details
Table 181. mFluiDx Business Overview
Table 182. mFluiDx Isothermal Nucleic Acid Amplification Technology (INAAT)Product
Table 183. mFluiDx Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 184. mFluiDx Recent Development
Table 185. Cangene Company Details
Table 186. Cangene Business Overview
Table 187. Cangene Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 188. Cangene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021) & (US$ Million)
Table 189. Cangene Recent Development
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Type: 2020 VS 2027
Figure 2. Loop-mediated Isothermal Amplification Features
Figure 3. Nucleic Acid Sequence-based Amplification Features
Figure 4. Rolling Circle Amplification Features
Figure 5. Single Primer Isothermal Amplification Features
Figure 6. Helicase-dependent Isothermal DNA Amplification Features
Figure 7. Recombinase Polymerase Amplification Features
Figure 8. Strand Displacement Amplification Features
Figure 9. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Application: 2020 VS 2027
Figure 10. Infectious Disease Diagnosis Case Studies
Figure 11. Blood Screening Case Studies
Figure 12. Cancer Diagnosis Case Studies
Figure 13. Cancer Research and Laboratory Research Case Studies
Figure 14. Other Case Studies
Figure 15. Isothermal Nucleic Acid Amplification Technology (INAAT) Report Years Considered
Figure 16. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Regions: 2020 VS 2027
Figure 19. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Regions (2022-2027)
Figure 20. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Players in 2020
Figure 21. Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue in 2020
Figure 23. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Type (2016-2021)
Figure 24. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Type (2022-2027)
Figure 25. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Type (2016-2027)
Figure 27. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Application (2016-2027)
Figure 28. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Country (2016-2027)
Figure 29. United States Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Type (2016-2027)
Figure 33. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Application (2016-2027)
Figure 34. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Country (2016-2027)
Figure 35. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Region (2016-2027)
Figure 45. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Type (2016-2027)
Figure 53. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Application (2016-2027)
Figure 54. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Country (2016-2027)
Figure 55. Mexico Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Country (2016-2027)
Figure 61. Turkey Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Grifols Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 65. Hologic Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 66. Abbott Laboratories Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 67. BD Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 68. Meridian Bioscience Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 69. Eiken Chemical Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 70. Quidel Corporation Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 71. QIAGEN Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 72. bioMerieux Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 73. Tecan Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 74. DiaSorin Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 75. Thermo Fisher Scientific Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 76. Illumina Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 77. New England Biolabs Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 78. TwistDx Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 79. Mast Group Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 80. Lucigen Corporation Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 81. Ustar Biotechnologies Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 82. Genomtec Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 83. Jena Bioscience Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 84. OptiGene Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 85. Sysmex Corporation Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 86. Premier Biosoft Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 87. mFluiDx Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 88. Cangene Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2016-2021)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed


【掲載企業】

Grifols、Hologic、Abbott Laboratories、BD、Meridian Bioscience、Eiken Chemical、Quidel Corporation、QIAGEN、bioMerieux、Tecan、DiaSorin、Thermo Fisher Scientific、Illumina、New England Biolabs、TwistDx、Mast Group、Lucigen Corporation、Ustar Biotechnologies、Genomtec、Jena Bioscience、OptiGene、Sysmex Corporation、Premier Biosoft、mFluiDx、Cangene

★調査レポート[世界の等温核酸増幅技術(INAAT)市場規模・現状・予測2021-2027] (コード:QY21APR3289)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の等温核酸増幅技術(INAAT)市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆